Multi-Modal Digital Monitoring of Disease Symptoms in Spinocerebellar Ataxia
Key facts
- Who runs it
- BioSensics
- Where
- Lutherville and New York, United StatesSee the 2 sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 25 people, planned
- Starts
- 15 Dec 2026
- Expected to end
- 31 Jan 2029
- Type of study
- Observational
- Record updated
- 1 October 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Male or female, aged 18-75 years
- Fluent in English (able to speak and read)
- Able to ambulate at least 10 meters independently or with a cane, without other assistive devices, as determined by the investigator
- Able to independently perform all study activities safely, as determined by the investigator
- Willing and able to provide informed consent and comply with all study procedures
- Genetically or clinically confirmed diagnosis of spinocerebellar ataxia (SCA 1, 2, 3, or 6)
Who cannot take part
- Individuals with a neurological, medical, or psychiatric condition (other than SCA) that, in the investigator's judgment, would interfere with safe participation in study activities or confound the assessment of ataxia
- Any condition that, in the investigator's judgment, would prevent the participant from completing the study procedures safely
- Individuals who are unable to ambulate at least 10 meters independently or with a cane
- Pregnant individuals, due to potential changes in gait and physical activity during pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- Johns Hopkins University School of MedicineLutherville, United StatesContact: Ashley KucharskiNot yet recruiting
- Columbia University Irving Medical Center/Neurological Institute of New YorkNew York, United StatesContact: Nadia AmokraneNot yet recruiting
About the trial
What the trial wants to find out
This is an observational study. Subjects with a documented diagnosis of spinocerebellar ataxia (SCA) will be screened and recruited to participate at two clinical sites: Johns Hopkins University (JHU) and Columbia University (CU).
Read full original descriptionShow less
Researchers at BioSensics, JHU, and CU will use wearable sensors computerized speech, psychomotor, and ocular assessments to evaluate the feasibility of using digital health technologies to monitor symptoms in SCA. Researchers will also measure the Scale for the Assessment and Rating of Ataxia (SARA) and other SCA clinical assessments.
The solution will be deployed for 25 participants with SCA for approximately 12 months with 5 study visits (Screening/Baseline, Day 1, Day 30, Day 90, Day 180, Day 360).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Fit questions
- Built from NCT07851376, who can take part
- Record updated
- 1 October 2026